Please login to the form below

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?

We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also highlighted some pretty big issues in clinical research. For example, the world can see how the BAME community has been disproportionately affected by the coronavirus, which has also underlined how unrepresentative clinical trials are of them. And over the last few weeks, we’ve been looking at other populations who are also being left behind.

The LGBTQ+ community have faced a history of marginalisation in clinical trials, leading to challenges and barriers that still deter them from taking part. According to research from the LGBT Foundation, LGBTQ+ people are:

  • Less likely to access healthcare when they need it
  • More likely to be living with HIV
  • More likely to be homeless or insecurely housed
  • More likely to smoke
  • Less likely to be physically active or have a good diet

And as we began to look into the relationship between the LGBTQ+ community and clinical trials via social listening, we’ve seen that individuals face poorer health outcomes as a result of COVID-19…

Insights into the LGBTQ+ community and clinical trials

Of all the online content that we audited, we found it shocking that only 2% was positive, while the other 98% was neutral or negative. Just to give you an idea of what we mean, the most frequently occurring keywords associated with terms like ‘LGBTQ+’ and ‘clinical trials’ are predominantly negative and medical terms such as: “Undiagnosed HIV infection” and “Heart disease risk” - as well as talk around key evidence gaps, donor eligibility and lifestyle factors including diet, alcohol and recent sex.

Traditionally, members of the LGBTQ+ community have been seen as hard‐to‐reach populations for clinical trial recruitment due to historical stigmatisation. Only a decade ago, a review of the inclusion criteria in clinical trials indicated that exclusion of lesbians and gay men from clinical trials in the US isn’t uncommon, particularly in studies with sexual function as an end point. And another study found women were underrepresented in research in 7 out of the 11 disease categories, even when women were more likely to have the disease.

Fast forward to 2020, and COVID-19 clinical trial guidelines are being called out as demonstrating “archaic and homophobic rules” that prevent gay and bisexual men from participating due to blood and plasma donation guidance.

In light of this, our social listening report looks deeper into how LGBTQ+ people still face discrimination and stark health inequalities rooted in historical preconceptions. Plus, we highlight how clinical research will need to address these issues during and following the COVID-19 pandemic.

You can read the full report here:

Downloads

  LGBTQ+ and Clinical Trials
PDF File: 657.2 KB

13th July 2020

Downloads

  LGBTQ+ and Clinical Trials
PDF File: 657.2 KB

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need unconscious bias training.”
COUCH Health
How do ethnic minority groups in the U.S. view clinical trials?
This year, we decided to do the same with ethnic minority communities over in the United States (U.S.) too. Ultimately, we wanted to explore attitudes towards clinical trials from these communities, understand the barriers in participation, and determine what factors may influence people’s decisions to take part.
COUCH Health
Three things to consider when using social listening research for patient recruitment
We are looking at how patient research can power your patient recruitment campaign. A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. So, let’s get started…
COUCH Health
4 ways mobile ethnography studies can elevate your patient insights
How can we achieve more real-life, in-the-moment insights from different groups to understand their thoughts and behaviours? This is where ethnography studies come in.
COUCH Health
#DemandDiversity: We’re calling on the clinical trials industry to include us all
The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?
COUCH Health
Include Us All in Your Clinical Trials

COUCH Health